Case number 1:18-cv-00147
H. Lundbeck A/S et al v. Cipla Limited et al > Documents
| Date Field | Doc. No. | Description (Pages) |
|---|---|---|
| Jul 8, 2020 | 1 | Complaint (19) |
| Apr 22, 2020 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re [20] Consent Judgment, ***Civil Case Terminated. Signed by Judge Leonard P. Stark on 4/22/20. (ntl) |
| Apr 13, 2020 | 20 | Proposed Consent Judgment (4) Docket Text: PROPOSED CONSENT JUDGMENT between Plaintiffs and Cipla Limited and Cipla USA Inc. by H. Lundbeck A/S, Takeda Pharmaceutical Company Ltd., Takeda Pharmaceuticals America, Inc., Takeda Pharmaceuticals International AG, Takeda Pharmaceuticals U.S.A., Inc.. (Dellinger, Megan) |
| Jan 16, 2019 | N/A | Oral Order (0) Docket Text: ORAL ORDER: If during the history of this case, Plaintiff(s) and Defendant(s) jointly wish to schedule a form of alternative dispute resolution ("ADR"), such as mediation, with Judge Burke, they should contact chambers by e-mail at Deborah_Benyo@ded.uscourts.gov or by phone. Additionally, if either side wishes to speak ex parte with Judge Burke regarding ADR matters, they may contact chambers via e-mail or by phone to arrange a time for a call. Ordered by Judge Christopher J. Burke on 1/16/2019. Associated Cases: 1:18-cv-00088-LPS et al.(dlb) |
| Jan 10, 2019 | N/A | Case Referred to Mediation (0) Docket Text: CASE REFERRED to Magistrate Judge Christopher J. Burke for Mediation. Please see Standing Order dated January 20, 2016, regarding disclosure of confidential ADR communications. A link to the standing order is provided here for your convenience at http://www.ded.uscourts.gov/general-orders/magistrate-judges-standing-order-adr-mediation Associated Cases: 1:18-cv-00088-LPS et al.(cak) |
| Aug 21, 2018 | N/A | CORRECTING ENTRY: (0) Docket Text: CORRECTING ENTRY: Correct document added to D.I. 8 per request of counsel. (ntl) |
| Jul 9, 2018 | N/A | Create Case Association (0) Docket Text: Case associated with lead case: Create association to 1:18-cv-00088-LPS. (ntl) |
| Jul 3, 2018 | 19 | Main Document (22) Docket Text: PROPOSED ORDER -- Scheduling Order -- by H. Lundbeck A/S, Takeda Pharmaceutical Company Ltd., Takeda Pharmaceuticals America, Inc., Takeda Pharmaceuticals International AG, Takeda Pharmaceuticals U.S.A., Inc.. (Attachments: # (1) Letter to The Honorable Leonard P. Stark)(Blumenfeld, Jack) |
| Jul 3, 2018 | 19 | Letter to The Honorable Leonard P. Stark (1) |
| Jul 3, 2018 | 19 | Proposed Order (22) |
| Jun 19, 2018 | N/A | Scheduling Conference (0) Docket Text: Minute Entry for proceedings held before Judge Leonard P. Stark - Case Management Conference held on 6/19/2018. (Court Reporter: Hawkins Reporting) Associated Cases: 1:18-cv-00088-LPS et al. (ntl) |
| Jun 12, 2018 | 18 | Main Document (23) Docket Text: PROPOSED ORDER Scheduling Order by H. Lundbeck A/S, Takeda Pharmaceutical Company Ltd., Takeda Pharmaceuticals America, Inc., Takeda Pharmaceuticals International AG, Takeda Pharmaceuticals U.S.A., Inc.. (Attachments: # (1) Cover Letter)(Blumenfeld, Jack) |
| Jun 12, 2018 | 18 | Cover Letter (1) |
| Jun 12, 2018 | 18 | Proposed Order (23) |
| Jun 8, 2018 | N/A | SO ORDERED (0) |
| Jun 6, 2018 | 17 | Stipulation to EXTEND Time (14) Docket Text: STIPULATION TO EXTEND TIME for the parties to submit a proposed Scheduling Order to June 12, 2018 - filed by H. Lundbeck A/S, Takeda Pharmaceutical Company Ltd., Takeda Pharmaceuticals America, Inc., Takeda Pharmaceuticals International AG, Takeda Pharmaceuticals U.S.A., Inc.. (Blumenfeld, Jack) |
| May 23, 2018 | N/A | Order Setting Scheduling Conference (0) Docket Text: ORAL ORDER: IT IS HEREBY ORDERED that the Court will hold a Case Management Conference in courtroom 6B on June 19, 2018 at 9:00 a.m. In preparation for the CMC, counsel shall meet and confer and address the items listed in the "Checklist," and submit a proposed scheduling order no later than June 6, 2018. ORDERED by Judge Leonard P. Stark on 5/23/18. Associated Cases: 1:18-cv-00088-LPS et al. (ntl) |
| May 21, 2018 | N/A | Add Attorneys Pro Hac Vice (0) Docket Text: Pro Hac Vice Attorney Aaron S. Eckenthal,William L. Mentlik,Tedd W. Van Buskirk for Cipla Limited, Cipla USA Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (crb) |
| Apr 30, 2018 | N/A | SO ORDERED (0) |
| Apr 27, 2018 | 15 | Motion for Leave to Appear Pro Hac Vice (6) Docket Text: MOTION for Pro Hac Vice Appearance of Attorney William L. Mentlik, Attorney Tedd W. Van Buskirk, and Attorney Aaron S. Eckenthal - filed by Cipla Limited, Cipla USA Inc.. (Pascale, Karen) |
| Apr 26, 2018 | N/A | SO ORDERED (0) |
| Apr 25, 2018 | 14 | Motion for Leave to Appear Pro Hac Vice (19) Docket Text: MOTION for Pro Hac Vice Appearance of Attorney George F. Pappas, Einar Stole, and Brianne Bharkhda of Covington & Burling LLP - filed by H. Lundbeck A/S, Takeda Pharmaceutical Company Ltd., Takeda Pharmaceuticals America, Inc., Takeda Pharmaceuticals International AG, Takeda Pharmaceuticals U.S.A., Inc.. (Dellinger, Megan) |
| Apr 23, 2018 | 13 | Answer to Counterclaim (12) Docket Text: ANSWER to [11] Answer to Complaint,, Counterclaim, -- Answer to Counterclaims -- by H. Lundbeck A/S, Takeda Pharmaceuticals America, Inc., Takeda Pharmaceuticals International AG, Takeda Pharmaceuticals U.S.A., Inc..(Blumenfeld, Jack) |
| Apr 2, 2018 | 12 | Disclosure Statement (3) Docket Text: Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent InvaGen Pharmaceuticals, Inc. for Cipla USA Inc. filed by Cipla Limited, Cipla USA Inc.. (Pascale, Karen) |
| Apr 2, 2018 | 11 | Answer to Complaint (21) Docket Text: ANSWER to [1] Complaint, , COUNTERCLAIM against H. Lundbeck A/S, Takeda Pharmaceutical Company Ltd., Takeda Pharmaceuticals America, Inc., Takeda Pharmaceuticals International AG, Takeda Pharmaceuticals U.S.A., Inc. by Cipla Limited, Cipla USA Inc..(Pascale, Karen) |
| Feb 1, 2018 | 10 | Waiver of Service Executed (1) Docket Text: WAIVER OF SERVICE returned executed by H. Lundbeck A/S, Takeda Pharmaceuticals U.S.A., Inc., Takeda Pharmaceuticals International AG, Takeda Pharmaceuticals America, Inc., Takeda Pharmaceutical Company Ltd.: For Cipla USA Inc. waiver sent on 1/31/2018, answer due 4/2/2018. (Noreika, Maryellen) |
| Feb 1, 2018 | 9 | Request for Waiver of Service (1) Docket Text: REQUEST FOR WAIVER of Service sent to Cipla USA, Inc. on 1/31/2018 by H. Lundbeck A/S, Takeda Pharmaceutical Company Ltd., Takeda Pharmaceuticals America, Inc., Takeda Pharmaceuticals International AG, Takeda Pharmaceuticals U.S.A., Inc.. Waiver of Service due by 3/5/2018. (Noreika, Maryellen) |
| Feb 1, 2018 | 8 | Waiver of Service Executed (1) Docket Text: WAIVER OF SERVICE returned executed by H. Lundbeck A/S, Takeda Pharmaceuticals U.S.A., Inc., Takeda Pharmaceuticals International AG, Takeda Pharmaceuticals America, Inc., Takeda Pharmaceutical Company Ltd.: For Cipla Limited waiver sent on 1/31/2018, answer due 4/2/2018. (Noreika, Maryellen) (Main Document 8 replaced on 8/21/2018) (ntl). |
| Feb 1, 2018 | 7 | Request for Waiver of Service (1) Docket Text: REQUEST FOR WAIVER of Service sent to Cipla Limited on 1/31/2018 by H. Lundbeck A/S, Takeda Pharmaceutical Company Ltd., Takeda Pharmaceuticals America, Inc., Takeda Pharmaceuticals International AG, Takeda Pharmaceuticals U.S.A., Inc.. Waiver of Service due by 3/5/2018. (Noreika, Maryellen) |
| Jan 31, 2018 | N/A | Case Assigned/Reassigned (0) Docket Text: Case Assigned to Judge Leonard P. Stark. Please include the initials of the Judge (LPS) after the case number on all documents filed. Associated Cases: 1:18-cv-00147-LPS, 1:18-cv-00148-LPS, 1:18-cv-00149-LPS, 1:18-cv-00150-LPS (rjb) |
| Jan 26, 2018 | N/A | Summons Issued (0) Docket Text: Summons Issued with Magistrate Consent Notice attached as to Cipla Limited on 1/26/2018; Cipla USA Inc. on 1/26/2018. Requesting party or attorney should pick up issued summons at the Help Desk, Room 4209, or call 302-573-6170 and ask the Clerk to mail the summons to them. (nmfn) |
| Jan 25, 2018 | 6 | Disclosure Statement (2) Docket Text: Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Takeda Pharmaceuticals U.S.A., Inc. for Takeda Pharmaceuticals America, Inc.; Corporate Parent Takeda Pharmaceutical Company Ltd., Corporate Parent Takeda Pharmaceuticals International AG for Takeda Pharmaceuticals U.S.A., Inc.; Corporate Parent Takeda Pharmaceutical Company Ltd., Corporate Parent Takeda Pharma A/S, Corporate Parent Takeda Europe Holdings B.V., Corporate Parent Takeda A/S for Takeda Pharmaceuticals International AG filed by Takeda Pharmaceutical Company Ltd., Takeda Pharmaceuticals America, Inc., Takeda Pharmaceuticals International AG, Takeda Pharmaceuticals U.S.A., Inc. (nmfn) |
| Jan 25, 2018 | 5 | Disclosure Statement (2) Docket Text: Disclosure Statement pursuant to Rule 7.1: No Parents or Affiliates Listed filed by H. Lundbeck A/S. (nmfn) |
| Jan 25, 2018 | 4 | Patent/Trademark Report to Commissioner (1) Docket Text: Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 8,722,684 B2; 8,969,355 B2; 9,227,946 B2. (nmfn) |
| Jan 25, 2018 | 3 | ANDA Form (1) Docket Text: Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: 12/15/2017. Date of Expiration of '355 and '946 Patents: 6/15/2027. Date of Expiration of '684 Patent: 6/30/2031.Thirty Month Stay Deadline: 3/30/2021.(nmfn) |
| Jan 25, 2018 | 2 | Magistrate Consent Forms (3) Docket Text: Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (nmfn) |
| Jan 25, 2018 | 1 | Main Document (19) Docket Text: COMPLAINT FOR PATENT INFRINGEMENT filed against Cipla Limited, Cipla USA Inc. - Magistrate Consent Notice to Pltf. ( Filing fee $ 400, receipt number 0311-2309312.) - filed by H. Lundbeck A/S, Takeda Pharmaceuticals U.S.A., Inc., Takeda Pharmaceuticals International AG, Takeda Pharmaceuticals America, Inc., Takeda Pharmaceutical Company Ltd. (Attachments: # (1) Exhibits A-C, # (2) Civil Cover Sheet)(nmfn) |
| Jan 25, 2018 | 1 | Civil Cover Sheet (2) |
| Jan 25, 2018 | 1 | Exhibits A-C (144) |
| Jan 25, 2018 | 1 | Complaint* (1) |
